Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1997-02-21
1998-02-17
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
057191913
ABSTRACT:
The present invention provides novel methods of inhibiting Alzheimer's Disease comprising administering to a human in need of treatment an effective amount of a compound of formula I ##STR1## wherein R.sup.1 and R.sup.2 may be the same or different provided that, when R.sup.1 and R.sup.2 are the same, each is a methyl or ethyl group, and, when R.sup.1 and R.sup.2 are different, one of them is a methyl or ethyl group and the other is hydrogen or a benzyl group; or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 5047431 (1991-09-01), Schickaneder et al.
patent: 5254594 (1993-10-01), Niikura et al.
patent: 5384332 (1995-01-01), Fontana
patent: 5441986 (1995-08-01), Thompson
patent: 5455275 (1995-10-01), Fontana
patent: 5550164 (1996-08-01), Fontana
Honjo, H., et al., "Senile Dementia-Alzheimer's Type and Estrogen," Morm. metab. Res. 27 (1995) 204-207.
MacLean David B.
Thompson David D.
Benson Gregg C.
Brokke Mervin E.
Goldberg Jerome D.
Pfizer Inc.
Richardson Peter C.
LandOfFree
1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's di does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's di, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's di will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784432